Glycaemic control and plasma lipoproteins in menopausal women with Type 2 diabetes treated with oral and transdermal combined hormone replacement therapy
- 1 December 2001
- journal article
- clinical trial
- Published by Elsevier BV in Diabetes Research and Clinical Practice
- Vol. 54 (3), 157-164
- https://doi.org/10.1016/s0168-8227(01)00297-2
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The Effect Of 17β-Estradiol and α-Tocopherol on the Oxidation of LDL Cholesterol From Postmenopausal Women and the Minor Effect of γ-Tocopherol and Melatonin*Menopause, 2000
- Acute Activation of Maxi-K Channels ( hSlo ) by Estradiol Binding to the β SubunitScience, 1999
- Hepatic lipaseCurrent Opinion in Lipidology, 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Estrogen Replacement Therapy Decreases Hyperandrogenicity and Improves Glucose Homeostasis and Plasma Lipids in Postmenopausal Women With Noninsulin-Dependent Diabetes MellitusJournal of Clinical Endocrinology & Metabolism, 1997
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Influence of age and menopause on serum lipids and lipoproteins in healthy womenAtherosclerosis, 1993
- Estrogens inhibit copper and cell-mediated modification of low density lipoproteinAtherosclerosis, 1991
- Menopause and Risk Factors for Coronary Heart DiseaseNew England Journal of Medicine, 1989
- Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement TherapyNew England Journal of Medicine, 1981